Charles River Laboratories International Depreciation & Amortization 2011-2026 | CRL

Annual Depreciation & Amortization Charles River Laboratories International

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
403 M	362 M	314 M	304 M	266 M	235 M	198 M	162 M	131 M	127 M	94.9 M	96.4 M	96.6 M	81.3 M	85.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
403 M	81.3 M	197 M

Quarterly Depreciation & Amortization Charles River Laboratories International

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
85.2 M	120 M	120 M	-	88.2 M	86.1 M	85.4 M	-	78.9 M	77.7 M	77.1 M	-	74.6 M	76.4 M	75.3 M	-	68.7 M	68.1 M	61.5 M	-	59.6 M	57.2 M	57.3 M	-	51.8 M	49.1 M	45.4 M	-	43.6 M	43.4 M	33.2 M	-	33.5 M	31.8 M	32.4 M	-	34.1 M	32.4 M	24.7 M	-	23.8 M	23.1 M	22.4 M	-	26.1 M	24.3 M	20 M	-	67.3 M	40.4 M	20 M	-	60.6 M	40.1 M	20 M	-	64.2 M	43.1 M	21.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
120 M	20 M	53.1 M

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Castle Biosciences CSTL	40.8 M	$ 19.75	-20.22 %	$ 572 M	USA
Burning Rock Biotech Limited BNR	47.8 M	$ 17.17	0.94 %	$ 181 M	China
Agilent Technologies A	321 M	$ 118.47	0.66 %	$ 36 B	USA
Medpace Holdings MEDP	27.2 M	$ 430.5	0.87 %	$ 12.4 B	USA
Myriad Genetics MYGN	53.7 M	$ 4.08	-0.85 %	$ 378 M	USA
NeoGenomics NEO	36.1 M	$ 9.02	1.41 %	$ 1.16 B	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
National Research Corporation NRC	7.62 M	$ 17.85	-0.06 %	$ 400 M	USA
Natera NTRA	16.7 M	$ 214.99	-0.05 %	$ 21.2 B	USA
Koninklijke Philips N.V. PHG	1.12 B	$ 27.43	0.72 %	$ 26 B	Niderland
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Personalis PSNL	10.9 M	$ 5.97	-1.65 %	$ 354 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
Soleno Therapeutics SLNO	2.02 M	$ 52.92	-0.04 %	$ 2.69 B	USA
CareDx, Inc CDNA	15 M	$ 21.58	3.06 %	$ 1.15 B	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Co-Diagnostics CODX	1.11 M	$ 1.8	9.67 %	$ 2.39 M	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Twist Bioscience Corporation TWST	24.9 M	$ 58.34	-2.0 %	$ 3.49 B	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	24.9 M	$ 15.03	0.74 %	$ 454 M	USA
Guardant Health GH	39.7 M	$ 89.49	-3.0 %	$ 11.2 B	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
ICON Public Limited Company ICLR	488 M	$ 123.87	-0.21 %	$ 10.2 B	Irlanda
Illumina ILMN	354 M	$ 139.44	-2.2 %	$ 22.2 B	USA
Senseonics Holdings SENS	1.51 M	$ 5.21	-2.89 %	$ 217 M	USA
Interpace Biosciences IDXG	425 K	$ 2.04	-3.33 %	$ 9.02 M	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Biomerica BMRA	87 K	$ 2.17	-1.84 %	$ 4.98 M	USA
Thermo Fisher Scientific TMO	1.05 B	$ 471.91	-0.22 %	$ 178 B	USA
Lantheus Holdings LNTH	70.1 M	$ 90.65	5.22 %	$ 6.12 B	USA
Waters Corporation WAT	88.1 M	$ 345.8	-1.15 %	$ 20.6 B	USA
Laboratory Corporation of America Holdings LH	681 M	$ 258.68	0.68 %	$ 21.5 B	USA
Celcuity CELC	167 K	$ 130.82	-6.18 %	$ 6.12 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	119 M	$ 9.22	0.44 %	$ 2 B	USA
Quest Diagnostics Incorporated DGX	570 M	$ 189.94	0.43 %	$ 21.1 B	USA